Results for tag: "Blood Cancer"

Blood cancer, also known as hematological cancer, is a type of cancer that affects the blood, bone marrow, and lymphatic system. It is a broad term that encompasses a variety of cancers, including leukemia, lymphoma, and myeloma. These cancers are caused by the abnormal production of blood cells, which can lead to anemia, infections, and other serious health problems. Treatment for blood cancer typically involves chemotherapy, radiation, and/or stem cell transplants. The blood cancer market is a rapidly growing segment of the hematology market. It is driven by the increasing prevalence of blood cancer, advances in treatment options, and the availability of new drugs. The market is expected to continue to grow in the coming years, as new treatments are developed and more patients are diagnosed. Some of the major companies in the blood cancer market include Novartis, Celgene, Amgen, Gilead Sciences, and Bristol-Myers Squibb. These companies are involved in the development and commercialization of drugs for the treatment of blood cancer. Show Less Read more